About
Illimis Therapeutics is a biotechnology company focused on translating cutting-edge science into innovative medicines for intractable diseases. Their core efforts include developing treatments for Alzheimer's disease, such as their GAIA-Aβ program aimed at overcoming limitations of existing therapies by addressing ARIA. They serve patients and their families suffering from debilitating conditions by striving to improve their quality of life through sustainable innovation.
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Illimis Therapeutics do?
Illimis Therapeutics is a biotechnology company focused on translating cutting-edge science into innovative medicines for intractable diseases. Their core efforts include developing treatments for Alzheimer's disease, such as their GAIA-Aβ program aimed at overcoming limitations of existing therapies by addressing ARIA. They serve patients and their families suffering from debilitating conditions by striving to improve their quality of life through sustainable innovation.
Where is Illimis Therapeutics headquartered?
Illimis Therapeutics is headquartered in Seoul, South Korea.
When was Illimis Therapeutics founded?
Illimis Therapeutics was founded in 2021.